147 lines
No EOL
71 KiB
XML
147 lines
No EOL
71 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK537033" /><meta name="ncbi_domain" content="statpearls" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK537033/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Campylobacter Infection - StatPearls - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="StatPearls [Internet]" /><meta name="citation_title" content="Campylobacter Infection" /><meta name="citation_publisher" content="StatPearls Publishing" /><meta name="citation_date" content="2024/01/10" /><meta name="citation_author" content="Greg H. Fischer" /><meta name="citation_author" content="Muhammad F. Hashmi" /><meta name="citation_author" content="Elizabeth Paterek" /><meta name="citation_pmid" content="30725718" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK537033/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Campylobacter Infection" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="StatPearls Publishing" /><meta name="DC.Contributor" content="Greg H. Fischer" /><meta name="DC.Contributor" content="Muhammad F. Hashmi" /><meta name="DC.Contributor" content="Elizabeth Paterek" /><meta name="DC.Date" content="2024/01/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK537033/" /><meta name="description" content="Campylobacter species represent one of the most common causes of bacterial diarrheal illness worldwide. According to the Centers for Disease Control (CDC), there are about 1.3 million cases of Campylobacter infection each year in the United States alone. This leads to an economic cost between $1.3 to $6.8 billion annually in the United States.[1] " /><meta name="og:title" content="Campylobacter Infection" /><meta name="og:type" content="book" /><meta name="og:description" content="Campylobacter species represent one of the most common causes of bacterial diarrheal illness worldwide. According to the Centers for Disease Control (CDC), there are about 1.3 million cases of Campylobacter infection each year in the United States alone. This leads to an economic cost between $1.3 to $6.8 billion annually in the United States.[1] " /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK537033/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-statpearls-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/statpearls/article-18790/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK537033/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8E8BB57D89B9D10000000000980087.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. </p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK537033_"><span class="title" itemprop="name">Campylobacter Infection</span></h1><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Greg H. Fischer</span><sup>1</sup>; <span itemprop="author">Muhammad F. Hashmi</span><sup>2</sup>; <span itemprop="author">Elizabeth Paterek</span><sup>3</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> Lake Erie College of Osteopathic Medicine at Seton Hill</div><div class="affiliation"><sup>2</sup> National Health Service</div><div class="affiliation"><sup>3</sup> Jefferson Northeast</div><p class="small">Last Update: <span itemprop="dateModified">January 10, 2024</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="article-18790.s1"><h2 id="_article-18790_s1_">Continuing Education Activity</h2><p>
|
||
<i>Campylobacter</i> is a bacterial species that represents an exceedingly common cause of diarrheal illness worldwide. This infection is associated with undercooked poultry, raw milk, and contaminated water consumption. Patients typically present with a self-limited diarrheal illness lasting 5 to 7 days. This activity illustrates the evaluation and management of <i>Campylobacter</i> and explains the role of the interprofessional team in improving care for patients with this condition.</p><p>Clinicians will enhance their knowledge of <i>Campylobacter</i> infections, including associated risk factors, clinical presentations, and geographical variations. Participants will also gain awareness of the increased risk of morbidity, mortality, and prolonged illness among immunocompromised and elderly patients. There is an emphasis on the role of the interprofessional team in improving care for patients with <i>Campylobacter</i>, providing clinicians with valuable insights to enhance patient outcomes. </p><p>
|
||
<b>Objectives:</b>
|
||
<ul><li class="half_rhythm"><div>Assess the etiology of <i>Campylobacter</i> infections.</div></li><li class="half_rhythm"><div>Identify emerging trends and variations in <i>Campylobacter</i> infections, including global epidemiological shifts.</div></li><li class="half_rhythm"><div>Select appropriate diagnostic methods for <i>Campylobacter</i>, considering the clinical context and the specific characteristics of the patient.</div></li><li class="half_rhythm"><div>Collaborate with an interdisciplinary team to address the multifaceted aspects of <i>Campylobacter</i> infections, fostering comprehensive patient care.</div></li></ul>
|
||
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=18790&utm_source=pubmed&utm_campaign=reviews&utm_content=18790" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
||
</p></div><div id="article-18790.s2"><h2 id="_article-18790_s2_">Introduction</h2><p>
|
||
<i>Campylobacter</i> species represent one of the most common causes of bacterial diarrheal illness worldwide. According to the Centers for Disease Control (CDC), there are about 1.3 million cases of <i>Campylobacter </i>infection each year in the United States alone. This leads to an economic cost between $1.3 to $6.8 billion annually in the United States.<a class="bk_pop" href="#article-18790.r1">[1]</a> </p><p>
|
||
<i>Campylobacter</i> infection is associated with consuming raw milk, undercooked poultry, and contaminated water. Patients typically experience a self-limited diarrheal illness lasting 5 to 7 days. Immunocompromised and elderly patients are at the highest risk for morbidity, mortality, and prolonged illness. There has been a dramatic increase in cases in developed and developing regions of the world despite having effective treatment and eradication modalities in animal reservoirs.<a class="bk_pop" href="#article-18790.r1">[1]</a></p><p>The major <i>Campylobacter</i> species considered human pathogens include <i>C. jejuni, C. coli,</i>
|
||
<i>C. fetus, </i>and<i> C. lari</i>. These species and others can cause bacteremia and systemic illness. <i>C. jejuni</i> infection causes serious bacteremic conditions in patients with acquired immune deficiency syndrome (AIDS). Most other reported cases of bacteremia are from <i>C. fetus </i>infection. <i>Campylobacter hyointestinalis,</i> with biochemical characteristics similar to those of <i>C. fetus,</i> causes occasional bacteremia in immunocompromised patients. <i>Campylobacter upsaliensis</i> can cause diarrhea or bacteremia. </p><p>
|
||
<i>Campylobacter</i> organisms are also a significant cause of traveler's diarrhea, particularly in Thailand and other areas of Southeast Asia.<a class="bk_pop" href="#article-18790.r2">[2]</a> In an observational study conducted on American military personnel deployed in Thailand, over half of those with diarrhea were observed to be infected with <i>Campylobacter</i> species.<a class="bk_pop" href="#article-18790.r3">[3]</a></p><p>Healthy seagulls harbor <i>C. lari,</i> which is reported to cause mild recurrent diarrhea in children.</p></div><div id="article-18790.s3"><h2 id="_article-18790_s3_">Etiology</h2><p>
|
||
<i>Campylobacter</i> bacteria is a motile, corkscrew-shaped gram-negative rod. These bacteria range in size from 0.5 to 5 microns in length by 0.2 to 0.9 microns in width. There are dozens of species. <i>C. jejuni</i> is the most commonly implicated species in human infections.<a class="bk_pop" href="#article-18790.r1">[1]</a></p><p>
|
||
<i>Campylobacter</i> is prevalent in food animals, including cattle, poultry, pigs, ostriches, sheep, and pets, such as cats and dogs.<a class="bk_pop" href="#article-18790.r4">[4]</a> Transmission to humans occurs via infected animals and food product consumption. Most human infections result from consuming contaminated or improperly cooked foodstuffs. Chicken accounts for 50% to 70% of <i>Campylobacter</i> infections in humans.</p><p>Transmission routes to humans include consumption of contaminated food and water, contact with animals, and person-to-person contact.<a class="bk_pop" href="#article-18790.r5">[5]</a> Exposure to sick pets, particularly puppies, is also associated with <i>Campylobacter</i> outbreaks.<a class="bk_pop" href="#article-18790.r6">[6]</a> <i>Campylobacter</i> has also been discovered in shellfish.<a class="bk_pop" href="#article-18790.r7">[7]</a></p><p>Volunteer-controlled studies have highlighted the relative virulence of <i>Campylobacter. </i>Infection with doses as low as 800 CFU can cause symptoms.<a class="bk_pop" href="#article-18790.r8">[8]</a> This virulence highlights the need for cleanliness in those who come into contact with infection reservoirs such as poultry, contaminated water, and raw dairy.</p></div><div id="article-18790.s4"><h2 id="_article-18790_s4_">Epidemiology</h2><p>
|
||
<i>Campylobacter</i> is a leading cause of diarrhea in both the developing and developed world and has become increasingly prevalent. In March 2013, the CDC reported a 14% increase in <i>C. jejuni</i> cases in the United States. One percent of the human population in Europe is affected annually by campylobacteriosis. In developing countries, <i>Campylobacter</i> isolation rates for food-borne illnesses are between 5% to 20%.</p><p>Campylobacteriosis can occur in all age groups, though it predominantly affects pediatric patients in developing countries. In the developed world, 90% of cases occur during the summer months, which is believed to be related to undercooked meat at outdoor facilities. The condition most commonly affects children younger than 4 years old and individuals between 15 to 44 years of age.<a class="bk_pop" href="#article-18790.r9">[9]</a></p><p>The worldwide prevalence of the disease highlights the ability of <i>Campylobacter </i>to survive in a wide range of environments. With the increasing popularity of international travel of humans and livestock, the spread of <i>Campylobacter</i> is challenging to control. The CDC has made efforts to educate the public about the signs and symptoms of disease and disease prevention for those traveling to countries with a high risk of contact with infected sources. These efforts include hand hygiene, separating raw meats from other food when cooking, thoroughly cooking food, and avoiding raw dairy and untreated water.</p></div><div id="article-18790.s5"><h2 id="_article-18790_s5_">Pathophysiology</h2><p>Symptoms of <i>Campylobacter</i> infection begin to appear after an incubation period of approximately 1 week. The affected body sites include the jejunum and the ileum and can extend to the colon and rectum. <i>C jejuni</i> invades and destroys epithelial cells. It is attracted to mucus; the flagella are essential in chemotaxis and adherence to mucus or epithelial cells. Such adherence promotes gut colonization. </p><p>Some strains of <i>C jejuni</i> release a heat-labile, cholera-like enterotoxin that plays an important role in infectious watery diarrhea. Infection with <i>Campylobacter</i> causes diffuse, bloody, exudative, and edematous enteritis. The inflammatory infiltrate contains neutrophils, eosinophils, and mononuclear cells. Crypt abscesses appear in the epithelial glands, and ulcers are seen in the mucosal epithelium.<a class="bk_pop" href="#article-18790.r10">[10]</a></p><p>Patients with bloody diarrhea due to <i>Campylobacter</i> infection have been found to demonstrate cytotoxin production. Rarely the infection is associated with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome through a poorly understood mechanism.<a class="bk_pop" href="#article-18790.r11">[11]</a> Endotoxins and immune complexes cause endothelial cell injury, followed by thrombotic microangiopathy and intravascular coagulation in the glomerulus and the gastrointestinal tract.</p></div><div id="article-18790.s6"><h2 id="_article-18790_s6_">History and Physical</h2><p>Infection from <i>Campylobacter </i>typically manifests as enteritis with voluminous diarrhea. Individuals may experience a prodromal phase of symptoms lasting 1 to 3 days. Symptoms of the prodromal phase include high fever, rigors, dizziness, and body aches. This prodromal phase is associated with a more severe disease course. The onset of symptoms typically occurs 24 to 72 hours following ingestion of the bacteria, though it may take longer to develop in individuals infected with smaller amounts of bacteria. The peak of illness generally lasts 24 to 48 hours.</p><p>The average time for the acute diarrheal phase of <i>Campylobacter </i>enteritis is approximately 7 days. It is not uncommon for symptoms of abdominal pain to persist for days to weeks after the resolution of diarrhea.<a class="bk_pop" href="#article-18790.r12">[12]</a> Patients may continue to excrete organisms in the feces for several weeks following clinical improvement, though patients receiving antimicrobial therapy appear to have a reduced likelihood of continued excretion.<a class="bk_pop" href="#article-18790.r13">[13]</a></p><p>During the acute phase of the illness, abdominal cramping and multiple episodes of diarrhea are common. Greater than 10 stools per day may occur. Bloody and mucous-like stools are common and result from the invasion of the epithelium by the bacteria in the intestine. This leads to inflammatory lesions and mucosal damage. Abdominal pain may mimic appendicitis due to acute ileocolitis.<a class="bk_pop" href="#article-18790.r14">[14]</a> Though pathogenesis is poorly understood, the plasmid pVir is associated with more invasive disease and an increased likelihood of bloody diarrhea.<a class="bk_pop" href="#article-18790.r15">[15]</a></p><p>Patients with <i>Campylobacter</i> infection can appear quite ill on examination. Abdominal examination may reveal diffuse tenderness, particularly in the right and left lower quadrants.</p></div><div id="article-18790.s7"><h2 id="_article-18790_s7_">Evaluation</h2><p>Stool culture, enzyme immunoassay (EIA), or polymerase chain reaction (PCR) can establish a diagnosis of <i>Campylobacter</i> infection. For a stool culture, colonies of <i>Campylobacter</i> species are grown using selective culture techniques designed to improve the isolation of <i>C. jejuni </i>and<i> C. coli</i><i>.</i> Both <i>C. jejuni</i> and <i>C. coli</i> are thermophilic, growing best at 42 °C, and are microaerophilic, growing best in an environment containing 5% to 10% oxygen.<a class="bk_pop" href="#article-18790.r9">[9]</a></p><p>EIA and PCR have shown increased sensitivity as compared to stool culture.<a class="bk_pop" href="#article-18790.r16">[16]</a> Recent developments using reverse transcription-polymerase chain reaction (RT-PCR) have allowed for more sensitive tests to screen potentially infected food sources.<a class="bk_pop" href="#article-18790.r17">[17]</a> Real-time PCR can quickly and accurately detect <i>C. jejuni</i> in the diarrheal stool.<a class="bk_pop" href="#article-18790.r18">[18]</a> Novel techniques, such as immunoenzymatic and molecular biology, are more sensitive than traditional culture.<a class="bk_pop" href="#article-18790.r19">[19]</a><a class="bk_pop" href="#article-18790.r20">[20]</a> Culture-independent tests, such as rapid testing for detecting antigens in stool, are available.<a class="bk_pop" href="#article-18790.r21">[21]</a> However, their utility as stand-alone tests is questionable.<a class="bk_pop" href="#article-18790.r22">[22]</a></p></div><div id="article-18790.s8"><h2 id="_article-18790_s8_">Treatment / Management</h2><p>Infection with <i>Campylobacter</i> is typically self-limiting and mild. The focus of interventions in healthy patients is hydration and electrolyte repletion. Hydration may be oral or parenteral, depending on the severity of the illness and the degree of dehydration. Anti-motility agents should be avoided as they can impede the resolution of the infection.<a class="bk_pop" href="#article-18790.r23">[23]</a> Antibiotics are not a mainstay of treatment in healthy patients. Antibiotics should be considered for high-risk patients such as immunocompromised and older individuals. Those with more severe disease exhibiting fever, bloody stools, or severe abdominal pain may also warrant antibiotics. Immunocompromised patients may require multiple courses of antibiotics.<a class="bk_pop" href="#article-18790.r24">[24]</a> When antibiotics are indicated,<i> Campylobacter</i> infections are best treated with macrolide antibiotics.<a class="bk_pop" href="#article-18790.r25">[25]</a> This is consistent with multiple patterns of antibiotic resistance that have emerged in recent years.</p><p>Antibiotic use in farm animals is believed to be the source of resistant strains. <i>Campylobacter</i> strains in Canada showed an 8.6% resistance to tetracyclines in 1981, increasing to 56% in more recent studies.<a class="bk_pop" href="#article-18790.r15">[15]</a> A significant resistance pattern to fluoroquinolone therapy has also emerged. While in the early 1990s, there was almost no fluoroquinolone resistance described in the literature, recent data in the United States shows a 40% fluoroquinolone resistance in one area of Pennsylvania.<a class="bk_pop" href="#article-18790.r26">[26]</a> </p><p>While resistance to macrolide antibiotics has remained low at 1% to 3% in the United States, there is a concern about the eventual development of resistant strains.<a class="bk_pop" href="#article-18790.r26">[26]</a> Patients failing antibiotics therapy require drug susceptibility testing. Research suggests that resistant strains emerge from widespread antibiotic use in farm animals. Advocacy for judicious antibiotic usage in large-scale farming environments has increased efforts to control antibiotic resistance.<a class="bk_pop" href="#article-18790.r27">[27]</a></p></div><div id="article-18790.s9"><h2 id="_article-18790_s9_">Differential Diagnosis</h2><p>The differential diagnosis of <i>Campylobacter </i>infection includes other sources of infectious bacterial diarrhea, such as:</p><ul><li class="half_rhythm"><div>
|
||
<i>Salmonella</i>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<i>Shigella</i>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<i>Escherichia coli</i>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<i>Listeria</i>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<i>Clostridium difficile</i>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<i>Yersinia Enterocolitica</i>
|
||
</div></li></ul><p>Viral gastroenteritis, such as norovirus, may also present similarly.<a class="bk_pop" href="#article-18790.r28">[28]</a> Toxin-mediated food poisoning can cause similar symptoms. Parasitic causes of diarrhea, including Giardia lamblia, Cryptosporidium parvum, and Entamoeba histolytica, may result in prolonged diarrhea in travelers and immunocompromised patients mimicking Campylobacter infection.<a class="bk_pop" href="#article-18790.r29">[29]</a></p><p>The abdominal pain from <i>Campylobacter</i> may mimic appendicitis and require advanced imaging such as ultrasound, CT scan, or MRI to differentiate. Inflammatory bowel disease, Crohn disease and ulcerative colitis may also present with abdominal pain and bloody stools. Stool culture, diagnostic imaging, biopsy, and colonoscopy diagnose these chronic conditions.<a class="bk_pop" href="#article-18790.r30">[30]</a></p></div><div id="article-18790.s10"><h2 id="_article-18790_s10_">Prognosis</h2><p>Generally, <i>Campylobacter</i> infection carries an excellent prognosis. It is almost always self-limiting, with or without specific therapy. The overall mortality for <i>Campylobacter</i> infection is 24 per 10,000 culture-confirmed cases. In healthy patients, <i>Campylobacter</i> infections have a self-limited course with excellent clinical outcomes. These patients require supportive care such as electrolyte repletion and oral and parenteral rehydration. Antibiotics should be considered in immunocompromised patients and those with fever, bloody diarrhea, numerous stools, or worsening symptoms. Approximately 10.8% of patients require hospitalization, making <i>Campylobacter</i> infection the third most common cause of hospitalization for gastroenteritis. Immunocompromised and older patients have the highest risks of prolonged and fatal illness. Most patients experience a complete resolution of illness without complications.<a class="bk_pop" href="#article-18790.r24">[24]</a></p><p>Fewer than 1% of patients experience transient bacteremia, which occurs during the acute infection. Bacteremia is associated with a mortality between 2.5% to 12.5%.<a class="bk_pop" href="#article-18790.r31">[31]</a> Immunocompromised and older patients are more likely to experience bacteremia.<a class="bk_pop" href="#article-18790.r32">[32]</a> HIV/AIDS patients have an increased incidence of infection with <i>Campylobacter</i> and a more virulent course. These patients may require multiple doses of antibiotic therapy. They are more likely to experience extraintestinal symptoms and higher mortality.<a class="bk_pop" href="#article-18790.r33">[33]</a></p></div><div id="article-18790.s11"><h2 id="_article-18790_s11_">Complications</h2><p>Numerous complications are associated with <i>Campylobacter</i> infection, many of which have a worse prognosis than the acute infection. In addition, <i>Campylobacter</i> infections can cause extraintestinal diseases involving the neurologic, cardiac, pulmonary, and immune systems.</p><p>In 1859, the French scientist Jean-Baptiste Octave Landry first reported the disease known today as Guillain-Barre syndrome (GBS). GBS is an autoimmune disease that presents with symmetrical ascending flaccid paralysis due to demyelination of peripheral nerves. However, it was not until the 20th century that a strong association between GBS and <i>Campylobacter</i> was made. Today, it is estimated that <i>Campylobacter</i>, particularly <i>C. jejuni,</i> provokes approximately 30% of all GBS<i>. </i>Approximately 1 in every 1000 people infected with <i>Campylobacter</i> will develop GBS. It occurs 1 to 3 weeks after infection with <i>Campylobacter</i>.</p><p>The mechanism of the autoimmune disease is thought to be through molecular mimicry, creating autoantibodies that react with peripheral nerves. The clinical course for those who suffer from GBS varies. Approximately 20% of patients with GBS have a complicated clinical course requiring prolonged intensive care. Despite the advances in the critical care management of GBS, it has a mortality between 3% to 7%.<a class="bk_pop" href="#article-18790.r17">[17]</a></p><p>Case reports have emerged of <i>Campylobacter</i>-associated<i> </i>myocarditis and pericarditis. This is most commonly described in young, healthy males with a history of traveling-associated diarrheal illness. Patients may experience symptoms ranging from mild chest discomfort to severe chest pain that mimics myocardial infarction. Laboratory testing often shows elevated troponin, creatine kinase, brain natriuretic peptide, and C-reactive protein. Increased levels of troponins have been associated with a worse prognosis. However, a normal value does not exclude the diagnosis of myocarditis. Echocardiography is used to identify associated pericardial effusions and wall motion abnormalities associated with the condition. In most patients, the clinical evolution of symptoms and outcomes is benign. Approximately 30% of those affected develop dilated cardiomyopathy. In severe cases, life-threatening arrhythmias and cardiovascular collapse requiring extracorporeal membrane oxygenation (ECMO) have been described.<a class="bk_pop" href="#article-18790.r34">[34]</a></p><p>Approximately 1% to 5% of patients will experience acute reactive arthritis, with an annual incidence of 4.3 per 100,000 cases. Young adults are the most commonly affected group. Both <i>C. jejuni</i> and <i>C. coli </i>are associated with the condition. Symptoms begin within the 4 weeks following acute infection, and the predominant symptom is sterile joint inflammation. Symptoms vary from mild oligoarthralgia to disabling polyarthritis. Musculoskeletal symptoms are the most common presentation, though patients can also have ocular, dermatological, and urinary symptoms. While symptoms commonly affect the knees and ankles, small joints and tendon involvement are also seen. The duration of symptoms in acute reactive arthritis is variable. Patients may experience symptoms lasting several months to 1 year. There is no association with HLA B27 on a population level.<a class="bk_pop" href="#article-18790.r35">[35]</a><a class="bk_pop" href="#article-18790.r36">[36]</a></p><p>In the gastrointestinal (GI) system, there has been an increased association of esophageal and colorectal diseases with <i>Campylobacter</i> infections. In the acute phase of the disease, severe infections can manifest as colitis, leading to significant morbidity, occasionally requiring surgical intervention. Toxic megacolon is a rare complication of <i>Campylobacter</i> colitis and should be considered in critically ill patients. Patients that develop toxic megacolon have high morbidity and mortality despite interventions.<a class="bk_pop" href="#article-18790.r37">[37]</a></p><p>Multiple other gastroenterological manifestations are associated with <i>Campylobacter,</i> including gastroesophageal reflux disease (GERD), Barrett esophagus (BE), and esophageal adenocarcinoma. Research has also shown an increased risk for irritable bowel disease and colorectal carcinoma following <i>Campylobacter </i>infections.<a class="bk_pop" href="#article-18790.r38">[38]</a></p><p>A form of lymphoma, immunoproliferative small intestinal disease, has shown an association with <i>Campylobacter</i> infections. Biopsy specimens of several patients noted the presence of <i>C. jejuni,</i> and antimicrobial therapy targeting this organism led to the rapid remission of the immunoproliferative small intestinal disease.<a class="bk_pop" href="#article-18790.r39">[39]</a></p></div><div id="article-18790.s12"><h2 id="_article-18790_s12_">Deterrence and Patient Education</h2><p>The most commonly reported sources of <i>Campylobacter</i> infections are under-cooked poultry in the developed world and contaminated water in the developing world. Ensuring poultry and meat are thoroughly cooked at 70 °C before ingestion decreases the risk of infection. The CDC recommends washing items that come into contact with raw poultry. They also recommend separate cutting boards for raw meat and cleaning utensils after coming in contact with raw meat.<a class="bk_pop" href="#article-18790.r1">[1]</a> </p><p>Unpasteurized milk and cheese should be avoided. Untreated water should not be consumed. Practicing basic hand hygiene also decreases the risk of infection.<a class="bk_pop" href="#article-18790.r40">[40]</a></p></div><div id="article-18790.s13"><h2 id="_article-18790_s13_">Pearls and Other Issues</h2><p>Key facts to keep in mind regarding<i> Campylobacter </i>infection are as follows: </p><ul><li class="half_rhythm"><div><i>Campylobacter</i> is a leading cause of foodborne illness worldwide. <i>C jejuni </i>is identified as the most common culprit in human infections.                                                                                                                </div></li><li class="half_rhythm"><div><i>Campylobacter</i> is a robust species of bacteria that can survive over a wide range of environments. Small numbers of bacteria can cause infection.                                                                                                     </div></li><li class="half_rhythm"><div>Those at most significant risk for infection include international travelers, people who come in frequent contact with livestock, and consumers of untreated water or unpasteurized milk. </div></li><li class="half_rhythm"><div>Clinically, <i>Campylobacter</i> infection typically manifests as diarrhea (sometimes bloody) that typically peaks 1 to 2 days following onset. The acute enteritis phase of the infection is typically self-limiting and resolves after 7 days.</div></li><li class="half_rhythm"><div>Stool culture, PCR, or EIA establish the diagnosis.</div></li><li class="half_rhythm"><div><i>Campylobacter</i> is typically self-limiting and, in some cases, requires supportive fluid and electrolyte replenishment. When antibiotics are needed, macrolides such as azithromycin are the treatment of choice.</div></li><li class="half_rhythm"><div>Multiple complications are related to <i>Campylobacter</i> infection; most notably, there is an association between infection and Guillain-Barre syndrome.<a class="bk_pop" href="#article-18790.r41">[41]</a></div></li></ul></div><div id="article-18790.s14"><h2 id="_article-18790_s14_">Enhancing Healthcare Team Outcomes </h2><p>Recent outbreaks of <i>Campylobacter</i> underline the importance of epidemiologic reporting, preventative measures, and interprofessional team collaboration. In 2018, there was a multi-state outbreak of <i>Campylobacter</i> with 113 laboratory-confirmed cases spanning over 17 states. This outbreak led to 23 hospitalizations with no reported deaths. During interviews with the patients, those affected answered a survey of questions regarding recent contact with animals and food. Questionnaires revealed 87% of those affected reported contact with a puppy from the same store branch. Biologists isolated genetic sequences that proved the samples were related using a gene sequencing method called whole genome sequencing.<a class="bk_pop" href="#article-18790.r42">[42]</a> This established a common source. Isolates were tested for antibiotic sensitivities, and a resistance pattern was identified. The infection was contained by identifying the pathogen, tracing its source, and providing treatment recommendations.</p><p>Healthcare professionals need clinical expertise in diagnosing and treating <i>Campylobacter</i> infections, including proficiency in interpreting diagnostic tests and assessing patient presentations. Competence in evidence-based practices and the ability to adapt to emerging trends in <i>Campylobacter</i> epidemiology are crucial. Healthcare professionals are responsible for providing patient-centered care, emphasizing timely and accurate diagnosis, appropriate treatment, and ongoing monitoring. This includes addressing the unique challenges <i>Campylobacter</i> infections pose in immunocompromised and high-risk populations. </p><p>Ensuring patient safety involves minimizing the risk of <i>Campylobacter</i>-related complications, adverse reactions to treatments, and preventing the spread of infections. Adherence to infection control protocols and vigilant monitoring contribute to a safer healthcare environment. Continuous monitoring and evaluation of patient outcomes related to <i>Campylobacter</i> infections are essential. This includes assessing the effectiveness of interventions, identifying areas for improvement, and implementing changes to optimize care delivery and enhance overall patient outcomes.</p><p>
|
||
<i>Campylobacter </i>infection must be prevented by practicing proper hygiene and food handling. The role of the interprofessional team in managing patients with <i>Campylobacter</i> is critical. This team should involve primary care providers, community nurses, preventative medicine, and gastroenterologists if indicated. If a patient develops complications, an appropriate specialist should be consulted, such as a neurologist in the case of GBS.</p><p>Coordinated efforts among healthcare team members are crucial for comprehensive <i>Campylobacter</i> care. This involves seamless collaboration in planning, implementing, and monitoring treatment, as well as facilitating patient education and follow-up care. Developing and implementing effective strategies for <i>Campylobacter</i> prevention, management, and patient education is essential. This includes creating protocols for early detection, treatment algorithms, and public health initiatives to reduce the overall burden of <i>Campylobacter</i> infections. </p><p>Health professionals must work collaboratively to enhance team performance. Regular training, ongoing education, and fostering a culture of mutual respect and communication contribute to a high-functioning, cohesive healthcare team focused on providing optimal care for patients with <i>Campylobacter</i> infections.</p></div><div id="article-18790.s15"><h2 id="_article-18790_s15_">Review Questions</h2><ul><li class="half_rhythm"><div>
|
||
<a href="https://www.statpearls.com/account/trialuserreg/?articleid=18790&utm_source=pubmed&utm_campaign=reviews&utm_content=18790" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Access free multiple choice questions on this topic.</a>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<a href="https://mdsearchlight.com/gut-health/campylobacter-infection/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=18790" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Click here for a simplified version.</a>
|
||
</div></li><li class="half_rhythm"><div>
|
||
<a href="https://www.statpearls.com/articlelibrary/commentarticle/18790/?utm_source=pubmed&utm_campaign=comments&utm_content=18790" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Comment on this article.</a>
|
||
</div></li></ul></div><div class="floats-group" id="article-18790.s16"></div><div id="article-18790.s17"><h2 id="_article-18790_s17_">References</h2><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="article-18790.r1">Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global Epidemiology of Campylobacter Infection. <span><span class="ref-journal">Clin Microbiol Rev. </span>2015 Jul;<span class="ref-vol">28</span>(3):687-720.</span> [<a href="/pmc/articles/PMC4462680/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4462680</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26062576" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26062576</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="article-18790.r2">Serichantalergs O, Ruekit S, Pandey P, Anuras S, Mason C, Bodhidatta L, Swierczewski B. Incidence of <em>Campylobacter concisus</em> and <em>C. ureolyticus</em> in traveler's diarrhea cases and asymptomatic controls in Nepal and Thailand. <span><span class="ref-journal">Gut Pathog. </span>2017;<span class="ref-vol">9</span>:47.</span> [<a href="/pmc/articles/PMC5561605/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5561605</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28824712" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28824712</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="article-18790.r3">Sanders JW, Isenbarger DW, Walz SE, Pang LW, Scott DA, Tamminga C, Oyofo BA, Hewitson WC, Sanchez JL, Pitarangsi C, Echeverria P, Tribble DR. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. <span><span class="ref-journal">Am J Trop Med Hyg. </span>2002 Nov;<span class="ref-vol">67</span>(5):533-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12479558" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12479558</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="article-18790.r4">Newell DG, Fearnley C. Sources of Campylobacter colonization in broiler chickens. <span><span class="ref-journal">Appl Environ Microbiol. </span>2003 Aug;<span class="ref-vol">69</span>(8):4343-51.</span> [<a href="/pmc/articles/PMC169125/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC169125</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12902214" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12902214</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="article-18790.r5">Sibanda N, McKenna A, Richmond A, Ricke SC, Callaway T, Stratakos AC, Gundogdu O, Corcionivoschi N. A Review of the Effect of Management Practices on <em>Campylobacter</em> Prevalence in Poultry Farms. <span><span class="ref-journal">Front Microbiol. </span>2018;<span class="ref-vol">9</span>:2002.</span> [<a href="/pmc/articles/PMC6117471/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6117471</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30197638" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30197638</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="article-18790.r6">Kuhn KG, Hvass AK, Christiansen AH, Ethelberg S, Cowan SA. Sexual Contact as Risk Factor for Campylobacter Infection, Denmark. <span><span class="ref-journal">Emerg Infect Dis. </span>2021 Apr;<span class="ref-vol">27</span>(4):1133-1140.</span> [<a href="/pmc/articles/PMC8007285/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8007285</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33754996" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 33754996</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="article-18790.r7">Rincé A, Balière C, Hervio-Heath D, Cozien J, Lozach S, Parnaudeau S, Le Guyader FS, Le Hello S, Giard JC, Sauvageot N, Benachour A, Strubbia S, Gourmelon M. Occurrence of Bacterial Pathogens and Human Noroviruses in Shellfish-Harvesting Areas and Their Catchments in France. <span><span class="ref-journal">Front Microbiol. </span>2018;<span class="ref-vol">9</span>:2443.</span> [<a href="/pmc/articles/PMC6193098/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6193098</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30364306" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30364306</span></a>]</div></dd><dt>8.</dt><dd><div class="bk_ref" id="article-18790.r8">Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. <span><span class="ref-journal">J Infect Dis. </span>1988 Mar;<span class="ref-vol">157</span>(3):472-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3343522" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3343522</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="article-18790.r9">Epps SV, Harvey RB, Hume ME, Phillips TD, Anderson RC, Nisbet DJ. Foodborne Campylobacter: infections, metabolism, pathogenesis and reservoirs. <span><span class="ref-journal">Int J Environ Res Public Health. </span>2013 Nov 26;<span class="ref-vol">10</span>(12):6292-304.</span> [<a href="/pmc/articles/PMC3881114/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3881114</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24287853" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24287853</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="article-18790.r10">Murphy H, Cogan T, Humphrey T. Direction of neutrophil movements by Campylobacter-infected intestinal epithelium. <span><span class="ref-journal">Microbes Infect. </span>2011 Jan;<span class="ref-vol">13</span>(1):42-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20934530" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20934530</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="article-18790.r11">Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV., Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. <span><span class="ref-journal">Neurology. </span>2001 Mar 27;<span class="ref-vol">56</span>(6):758-65.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11274311" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11274311</span></a>]</div></dd><dt>12.</dt><dd><div class="bk_ref" id="article-18790.r12">Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. <span><span class="ref-journal">N Engl J Med. </span>1999 May 20;<span class="ref-vol">340</span>(20):1525-32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10332013" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10332013</span></a>]</div></dd><dt>13.</dt><dd><div class="bk_ref" id="article-18790.r13">Kapperud G, Lassen J, Ostroff SM, Aasen S. Clinical features of sporadic Campylobacter infections in Norway. <span><span class="ref-journal">Scand J Infect Dis. </span>1992;<span class="ref-vol">24</span>(6):741-9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1287808" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1287808</span></a>]</div></dd><dt>14.</dt><dd><div class="bk_ref" id="article-18790.r14">Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. <span><span class="ref-journal">J Infect Dis. </span>1997 Dec;<span class="ref-vol">176 Suppl 2</span>:S103-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9396691" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9396691</span></a>]</div></dd><dt>15.</dt><dd><div class="bk_ref" id="article-18790.r15">Tracz DM, Keelan M, Ahmed-Bentley J, Gibreel A, Kowalewska-Grochowska K, Taylor DE. pVir and bloody diarrhea in Campylobacter jejuni enteritis. <span><span class="ref-journal">Emerg Infect Dis. </span>2005 Jun;<span class="ref-vol">11</span>(6):838-43.</span> [<a href="/pmc/articles/PMC3367571/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3367571</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15963277" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15963277</span></a>]</div></dd><dt>16.</dt><dd><div class="bk_ref" id="article-18790.r16">Platts-Mills JA, Liu J, Gratz J, Mduma E, Amour C, Swai N, Taniuchi M, Begum S, Peñataro Yori P, Tilley DH, Lee G, Shen Z, Whary MT, Fox JG, McGrath M, Kosek M, Haque R, Houpt ER. Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries. <span><span class="ref-journal">J Clin Microbiol. </span>2014 Apr;<span class="ref-vol">52</span>(4):1074-80.</span> [<a href="/pmc/articles/PMC3993515/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3993515</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24452175" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24452175</span></a>]</div></dd><dt>17.</dt><dd><div class="bk_ref" id="article-18790.r17">Bonilauri P, Bardasi L, Leonelli R, Ramini M, Luppi A, Giacometti F, Merialdi G. Detection of Food Hazards in Foods: Comparison of Real Time Polymerase Chain Reaction and Cultural Methods. <span><span class="ref-journal">Ital J Food Saf. </span>2016 Jan 18;<span class="ref-vol">5</span>(1):5641.</span> [<a href="/pmc/articles/PMC5076710/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5076710</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27800434" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27800434</span></a>]</div></dd><dt>18.</dt><dd><div class="bk_ref" id="article-18790.r18">Lin S, Wang X, Zheng H, Mao Z, Sun Y, Jiang B. Direct detection of Campylobacter jejuni in human stool samples by real-time PCR. <span><span class="ref-journal">Can J Microbiol. </span>2008 Sep;<span class="ref-vol">54</span>(9):742-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18772937" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18772937</span></a>]</div></dd><dt>19.</dt><dd><div class="bk_ref" id="article-18790.r19">Bessède E, Delcamp A, Sifré E, Buissonnière A, Mégraud F. New methods for detection of campylobacters in stool samples in comparison to culture. <span><span class="ref-journal">J Clin Microbiol. </span>2011 Mar;<span class="ref-vol">49</span>(3):941-4.</span> [<a href="/pmc/articles/PMC3067684/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3067684</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21209172" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21209172</span></a>]</div></dd><dt>20.</dt><dd><div class="bk_ref" id="article-18790.r20">Buss JE, Cresse M, Doyle S, Buchan BW, Craft DW, Young S. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods. <span><span class="ref-journal">Eur J Clin Microbiol Infect Dis. </span>2019 Jun;<span class="ref-vol">38</span>(6):1087-1093.</span> [<a href="/pmc/articles/PMC6520473/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6520473</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30783889" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30783889</span></a>]</div></dd><dt>21.</dt><dd><div class="bk_ref" id="article-18790.r21">Couturier BA, Couturier MR, Kalp KJ, Fisher MA. Detection of non-jejuni and -coli Campylobacter species from stool specimens with an immunochromatographic antigen detection assay. <span><span class="ref-journal">J Clin Microbiol. </span>2013 Jun;<span class="ref-vol">51</span>(6):1935-7.</span> [<a href="/pmc/articles/PMC3716065/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3716065</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23554192" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23554192</span></a>]</div></dd><dt>22.</dt><dd><div class="bk_ref" id="article-18790.r22">Fitzgerald C, Patrick M, Gonzalez A, Akin J, Polage CR, Wymore K, Gillim-Ross L, Xavier K, Sadlowski J, Monahan J, Hurd S, Dahlberg S, Jerris R, Watson R, Santovenia M, Mitchell D, Harrison C, Tobin-D'Angelo M, DeMartino M, Pentella M, Razeq J, Leonard C, Jung C, Achong-Bowe R, Evans Y, Jain D, Juni B, Leano F, Robinson T, Smith K, Gittelman RM, Garrigan C, Nachamkin I. Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from Stool. <span><span class="ref-journal">J Clin Microbiol. </span>2016 May;<span class="ref-vol">54</span>(5):1209-15.</span> [<a href="/pmc/articles/PMC4844741/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4844741</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26962088" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26962088</span></a>]</div></dd><dt>23.</dt><dd><div class="bk_ref" id="article-18790.r23">Nolan CM, Johnson KE, Coyle MB, Faler K. Campylobacter jejuni enteritis: efficacy of antimicrobial and antimotility drugs. <span><span class="ref-journal">Am J Gastroenterol. </span>1983 Oct;<span class="ref-vol">78</span>(10):621-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/6624735" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6624735</span></a>]</div></dd><dt>24.</dt><dd><div class="bk_ref" id="article-18790.r24">Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. <span><span class="ref-journal">Clin Infect Dis. </span>2007 Mar 01;<span class="ref-vol">44</span>(5):701-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17278063" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17278063</span></a>]</div></dd><dt>25.</dt><dd><div class="bk_ref" id="article-18790.r25">Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. <span><span class="ref-journal">Future Microbiol. </span>2009 Mar;<span class="ref-vol">4</span>(2):189-200.</span> [<a href="/pmc/articles/PMC2691575/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2691575</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19257846" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19257846</span></a>]</div></dd><dt>26.</dt><dd><div class="bk_ref" id="article-18790.r26">Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, Joyce KW, Smith KE, Jones TF, Hawkins MA, Shiferaw B, Beebe JL, Vugia DJ, Rabatsky-Ehr T, Benson JA, Root TP, Angulo FJ., NARMS Working Group. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. <span><span class="ref-journal">Emerg Infect Dis. </span>2004 Jun;<span class="ref-vol">10</span>(6):1102-9.</span> [<a href="/pmc/articles/PMC3323172/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3323172</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15207064" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15207064</span></a>]</div></dd><dt>27.</dt><dd><div class="bk_ref" id="article-18790.r27">Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. <span><span class="ref-journal">Clin Infect Dis. </span>2001 Apr 15;<span class="ref-vol">32</span>(8):1201-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11283810" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11283810</span></a>]</div></dd><dt>28.</dt><dd><div class="bk_ref" id="article-18790.r28">Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R. Etiological agents of infectious diarrhea: implications for requests for microbial culture. <span><span class="ref-journal">J Clin Microbiol. </span>1997 Jun;<span class="ref-vol">35</span>(6):1427-32.</span> [<a href="/pmc/articles/PMC229762/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC229762</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9163457" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9163457</span></a>]</div></dd><dt>29.</dt><dd><div class="bk_ref" id="article-18790.r29">Slack A. Parasitic causes of prolonged diarrhoea in travellers - diagnosis and management. <span><span class="ref-journal">Aust Fam Physician. </span>2012 Oct;<span class="ref-vol">41</span>(10):782-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23210100" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23210100</span></a>]</div></dd><dt>30.</dt><dd><div class="bk_ref" id="article-18790.r30">Mee AS, Shield M, Burke M. Campylobacter colitis: differentiation from acute inflammatory bowel disease. <span><span class="ref-journal">J R Soc Med. </span>1985 Mar;<span class="ref-vol">78</span>(3):217-23.</span> [<a href="/pmc/articles/PMC1289637/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1289637</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3973886" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3973886</span></a>]</div></dd><dt>31.</dt><dd><div class="bk_ref" id="article-18790.r31">Nielsen H, Hansen KK, Gradel KO, Kristensen B, Ejlertsen T, Østergaard C, Schønheyder HC. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. <span><span class="ref-journal">Clin Microbiol Infect. </span>2010 Jan;<span class="ref-vol">16</span>(1):57-61.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19673969" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19673969</span></a>]</div></dd><dt>32.</dt><dd><div class="bk_ref" id="article-18790.r32">Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL., CAMPYL Study Group. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. <span><span class="ref-journal">Clin Infect Dis. </span>2008 Sep 15;<span class="ref-vol">47</span>(6):790-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18699745" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18699745</span></a>]</div></dd><dt>33.</dt><dd><div class="bk_ref" id="article-18790.r33">Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. <span><span class="ref-journal">Clin Infect Dis. </span>1998 Jan;<span class="ref-vol">26</span>(1):91-6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9455515" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9455515</span></a>]</div></dd><dt>34.</dt><dd><div class="bk_ref" id="article-18790.r34">Inayat F, Ali NS, Riaz I, Virk HUH. From the Gut to the Heart: Campylobacter jejuni Enteritis Leading to Myopericarditis. <span><span class="ref-journal">Cureus. </span>2017 Jun 09;<span class="ref-vol">9</span>(6):e1326.</span> [<a href="/pmc/articles/PMC5501719/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5501719</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28690959" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28690959</span></a>]</div></dd><dt>35.</dt><dd><div class="bk_ref" id="article-18790.r35">Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. <span><span class="ref-journal">Semin Arthritis Rheum. </span>2007 Aug;<span class="ref-vol">37</span>(1):48-55.</span> [<a href="/pmc/articles/PMC2909271/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2909271</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17360026" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17360026</span></a>]</div></dd><dt>36.</dt><dd><div class="bk_ref" id="article-18790.r36">Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A, Leirisalo-Repo M. Campylobacter-triggered reactive arthritis: a population-based study. <span><span class="ref-journal">Rheumatology (Oxford). </span>2002 Mar;<span class="ref-vol">41</span>(3):312-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11934969" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11934969</span></a>]</div></dd><dt>37.</dt><dd><div class="bk_ref" id="article-18790.r37">Kwok M, Maurice A, Lisec C, Brown J. Campylobacter colitis: Rare cause of toxic megacolon. <span><span class="ref-journal">Int J Surg Case Rep. </span>2016;<span class="ref-vol">27</span>:141-143.</span> [<a href="/pmc/articles/PMC5018068/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018068</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27614338" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27614338</span></a>]</div></dd><dt>38.</dt><dd><div class="bk_ref" id="article-18790.r38">Macfarlane S, Furrie E, Macfarlane GT, Dillon JF. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. <span><span class="ref-journal">Clin Infect Dis. </span>2007 Jul 01;<span class="ref-vol">45</span>(1):29-38.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17554697" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17554697</span></a>]</div></dd><dt>39.</dt><dd><div class="bk_ref" id="article-18790.r39">Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. <span><span class="ref-journal">N Engl J Med. </span>2004 Jan 15;<span class="ref-vol">350</span>(3):239-48.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14724303" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14724303</span></a>]</div></dd><dt>40.</dt><dd><div class="bk_ref" id="article-18790.r40">Facciolà A, Riso R, Avventuroso E, Visalli G, Delia SA, Laganà P. <em>Campylobacter:</em> from microbiology to prevention. <span><span class="ref-journal">J Prev Med Hyg. </span>2017 Jun;<span class="ref-vol">58</span>(2):E79-E92.</span> [<a href="/pmc/articles/PMC5584092/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5584092</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28900347" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28900347</span></a>]</div></dd><dt>41.</dt><dd><div class="bk_ref" id="article-18790.r41">Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update. <span><span class="ref-journal">Biomed Res Int. </span>2013;<span class="ref-vol">2013</span>:852195.</span> [<a href="/pmc/articles/PMC3755430/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3755430</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24000328" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24000328</span></a>]</div></dd><dt>42.</dt><dd><div class="bk_ref" id="article-18790.r42">Lindsey RL, Gladney LM, Huang AD, Griswold T, Katz LS, Dinsmore BA, Im MS, Kucerova Z, Smith PA, Lane C, Carleton HA. Rapid identification of enteric bacteria from whole genome sequences using average nucleotide identity metrics. <span><span class="ref-journal">Front Microbiol. </span>2023;<span class="ref-vol">14</span>:1225207.</span> [<a href="/pmc/articles/PMC10752928/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC10752928</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38156000" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38156000</span></a>]</div></dd></dl></div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Greg Fischer declares no relevant financial relationships with ineligible companies.</p></div></dd><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p></div></dd><dt></dt><dd><div><p class="no_top_margin">
|
||
<b>Disclosure: </b>Elizabeth Paterek declares no relevant financial relationships with ineligible companies.</p></div></dd></dl></div><div class="bk_prnt_sctn"><h2>Figures</h2><div class="whole_rhythm bk_prnt_obj bk_first_prnt_obj"><div id="article-18790.image.f1" class="figure bk_fig"><div class="graphic"><img src="/books/NBK537033/bin/ARS_Campylobacter_jejuni.jpg" alt="A scanning electron microscope-derived image of Campylobacter jejuni, which triggers about 30% of cases of Guillain–Barré syndrome" /></div><div class="caption"><p>A scanning electron microscope-derived image of Campylobacter jejuni, which triggers about 30% of cases of Guillain–Barré syndrome. Contributed by Wikimedia Commons, De Wood, Pooley, USDA, ARS, EMU (PD USDA ARS)</p></div></div></div></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 2025, StatPearls Publishing LLC.<p class="small">
|
||
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
|
||
(<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">
|
||
http://creativecommons.org/licenses/by-nc-nd/4.0/
|
||
</a>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
|
||
</p></div><div class="small"><span class="label">Bookshelf ID: NBK537033</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30725718" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">30725718</a></span></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK537033&ncbi_domain=statpearls&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK537033/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |